The present study aims at integrating drug-releasing materials with signal-processing biocomputing systems. Enzymes alanine transaminase (ALT) and aspartate transaminase (AST)-biomarkers for liver injury-were logically processed by a biocatalytic cascade realizing Boolean AND gate. Citrate produced in the system was used to trigger a drugmimicking release from alginate microspheres. In order to differentiate low vs. high concentration signals, the microspheres were coated with a protective shell composed of layer-by-layer adsorbed poly(L-lysine) and alginate. The alginate core of the microspheres was prepared from Fe 3+
INTRODUCTION
The design of new controlled-release chemical systems has received considerable attention due to their advantages in various areas including fragrance release, 1 selfhealing materials 2, 3 and particularly for delivery of bioactive substances (drugs, vitamins, nutrients, contrasts for imaging, genes, etc.) in various biomedical applications. [4] [5] [6] [7] [8] [9] [10] The therapeutic potential of these systems is especially strong because they can provide solutions for the easy control of drug transport, tackling the problem of localized delivery to a specific site. [11] [12] [13] Various functional materials based on polymer thin-films, [14] [15] [16] membranes, 17 nanoporous 18 and mesoporous 19, 20 structures, capsules [21] [22] [23] and liposomes 24, 25 are capable of entrapping various molecular species and nano-objects and then releasing them in response to different physical or chemical signals. A variety of polymers [9] [10] [11] [12] have been used over the past few decades for encapsulating drugs and their subsequent delivery. Persistent challenges associated with loading of the desired molecules with high efficiency, preserving activity and stabilizing the encapsulated species, and preventing their leaching, require the development of new polymer materials and techniques to design systems with complex architectures. Among the different techniques, the polyelectrolyte layer-by-layer (LbL) self-assembly has emerged as an easily utilized and versatile tool. [26] [27] [28] [29] Based on alternating adsorption of polycations and polyanions, this technique allows films to be produced with tunable properties; an almost infinite variety of architectures can thus be obtained. [30] [31] [32] Stimuli-responsive LbLpolymeric assemblies have been used in particular for the controlled release of drugs. [33] [34] [35] [36] Alginate, a natural polymer, 37 due to its appealing adhesive and mechanical properties together with availability, compatibility with hydrophobic and hydrophilic molecules, and lack of toxicity, has attracted increasing interest. Alginate hydrogels, ionically crosslinked in the presence of multivalent cations, have been extensively investigated owing to their biocompatibility. 37 Notably, alginate hydrogels have been utilized as microcapsules that can release entrapped components either spontaneously or in response to changes in environmental conditions, through controlled degradation of the assembly. [38] [39] [40] [41] [42] [43] However, -3 -it is known that ionically cross-linked alginate hydrogel is not structurally stable, because of ion exchange, especially under physiological conditions, limiting its medical application. 37 A number of studies have attempted to address this problem by varying the molecular weight 44, 45 or/and cross-linking ions 45 of alginate. Since alginate contains carboxylic groups on polyguluronate units, alginate microspheres exhibit negative surface charge, 46 allowing them to be used as negatively charged templates for polyelectrolyte LbL assembly. Different polyelectrolytes have been used to coat alginate, [47] [48] [49] [50] [51] [52] [53] where the most common system involves alginate/poly-L-lysine/alginate (APA) assembly, [54] [55] [56] [57] derived from the original protocol of Lim and Sun. 58 This system consists of an alginate core ionically cross-linked with multivalent cations (often Ca 2+ ). 59 These microspheres are coated with poly(L-lysine) to strengthen the outer surface and control permeability, 60 followed by coating with a capping layer of adsorbed alginate to shield the cationic poly(L-lysine) from the environment and, thus, make the microcapsules biocompatible. 61 Due to the intrinsic ability of polymers to alter their physical and chemical properties in response to external stimuli, utilization of polymers in drug delivery fosters development of systems triggered by different signals, particularly by pH changes, [62] [63] [64] [65] [66] temperature variation 66 and presence of specific biomolecules (e.g., glucose). 66, 67 Biochemical reactions resulting in change of pH, temperature or increase/decrease in concentration of certain molecules can therefore initiate drug release. It is known that biochemically induced changes in physiological conditions often relate to the occurrence of a certain biological dysfunction or disease. Therefore design of systems triggered directly by changes in physiological conditions has been of high importance for medical diagnostics and physiologically regulated drug release. Thus far, triggered-release reactions have been accomplished via the interaction of signal-responsive materials with a single external signal, e.g., the presence of one specific kind of biomolecule. 66, 67 Development of signal-responsive materials recognizing the concentration changes of several biomolecules simultaneously and responding only to specific combinations of the (bio)chemical signals would enable new biomedical applications.
68
-4 -Information processing by biomolecules (shortly, "biocomputing"), 69, 70 originally studied as a sub-area of unconventional computing, 71, 72 has recently been researched as a new important tool for biosensing 73, 74 and bioactuating. 75 Biomedical application of biocomputing systems allows logic analysis of complex patterns of simultaneously varying biomarkers jointly characteristic of different pathophysiological conditions. [76] [77] [78] Particularly, enzyme-based biocomputing systems 79 in the form of single logic gates [80] [81] [82] or complex logic networks 83 were utilized for the analysis of biomarkers signaling different injury conditions. Integration of enzyme logic gates with switchable electrodes allowed activation of bioelectrochemical systems by appropriate combinations of biomarkers appearing at elevated pathophysiological concentrations. 84 It should be noted that the designed switchable bioelectrodes were controlled by complex patterns of biochemical signals 85 rather than a single physical or chemical signal.
The present paper represents the next step in the development of biochemical systems controlled by logically processed biochemical signals with the result that a drugmimicking material is released only when both biomarker-signals appeared at their high pathophysiological concentrations jointly indicative of liver injury. Thus, this work extends the research on multi-input biosensors with the built-in biomolecular logic to include an "actuator" which responds to the output signal of the binary logic processing.
The signal-triggered response was studied at the level of a single microsphere, yielding information on the release kinetics of the drug-mimicking dye.
EXPERIMENTAL SECTION
Chemicals and reagents. Alanine transaminase from porcine heart (ALT, E.C. 2.6.1.2), aspartate transaminase, type 1 (AST, E.C. 2.6.1.1), citrate synthase from porcine heart (E.C. 2.3. The characterization of the alginate hydrogel microspheres. The size distribution of the rhodamine 6G-loaded microspheres in aqueous solutions before drug-mimicking release was visualized by confocal microscopy. The rhodamine 6G dye was excited with a 488 nm argon laser and became visible using scanning laser confocal fluorescence microscopy under 10-objective lens. The produced microspheres ranged in size from 500 to 800 μm, however, only microspheres with the size of ca. 500 μm were selected for the experiments. FITC-labeled poly-L-lysine was used to visualize the poly-L-lysine layer applied to the microspheres. The microspheres treated with FITC-labeled poly-Llysine were produced in the same way as described above, however the addition of rhodamine 6G dye to the initial sodium alginate solution was skipped because the FITClabel has excitation and emission spectrum peaks (495 nm and 521 nm respectively) similar to those of rhodamine 6G.
The composition of the biocatalytical cascade for the liver injury analysis. Glutamic acid (10 mM), pyruvic acid (5 mM), aspartate sodium salt (50 mM), acetyl CoA (5 mM), and citrate synthase (1 U/mL) were dissolved in phosphate buffer saline (PBS) (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 ), pH = 7.4, to form the "machinery" of the system. Logical '0' and '1' levels of ALT (0.02 and 2 U/mL), and AST (0.02 and 2 U/mL) which correspond to the normal and pathophysiological biomarker concentrations, 86 respectively, were used as inputs A and B activating the biochemical "machinery" system. This system works as an AND gate, signaling presence of the liver injury when both inputs appear at their logic 1 concentrations. Production of citrate was indirectly measured for each combination of the inputs using interaction between DTNB 87, 88 reagent and a thiol group of CoASH which is produced by the biocatalytic cascade in 1:1 stoichiometry to citrate, see Scheme 1 (all the Schemes and
Figures are located at the end of this preprint, starting on page 25). For this analysis, after -7 -1 hour of the biocatalytic reaction, 50 μL aliquot of the reaction mixture was reacted with 10 μL of DTNB (0.1 mM) and the absorbance at 412 nm was used to calculate 87, 88 the concentration of the produced CoASH. The concentration of citrate was assumed to be the same. In order to determine the total amount of the loaded rhodamine 6G dye, individual microspheres were fully dissolved in 10 mM citrate solution for 30 min and the amount of the released rhodamine 6G was found by fluorescence measurements.
In vitro release study. In order to measure the rhodamine 6G dye release to the solution, 
RESULTS AND DISCUSSION
Scheme 1 shows the general composition and operation of the system with the drugmimicking release from the alginate microspheres triggered by a biocatalytic cascade activated by biomarkers signaling liver (hepatic) injury. This system is based on the recently developed concept of two non-specific biomarkers operating together, and it offers a high fidelity indication of liver injury when both biomarkers appear at their elevated pathophysiological concentrations. 73, 74, [80] [81] [82] The biomarker selection in each case is based on their biomedical relevance to the specific pathophysiological condition and on their ability to operate jointly in a biocatalytic cascade producing the final desired product. In order to provide a binary "YES/NO" conclusion on specific pathophysiological conditions, for an analytical application the end product generated by the biocatalytic cascade should be easily analyzed by optical [80] [81] [82] or electrochemical 81 means. The present work is focused on the actuation involved in the model drug release, and therefore the final product generated by the biocatalytic cascade should dissolve the alginate microcapsules, releasing the loaded dye.
Two enzymes, alanine transaminase (ALT) and aspartate transaminase (AST), were selected as biomarkers signaling liver injury. While they appear in human blood at concentration of 0.02 U/mL under normal physiological conditions, their elevated -9 -concentrations of 2 U/mL correspond to pathophysiological conditions characteristic of the liver injury. 86 Therefore, we defined 0.02 and 2 U/mL concentrations as logic inputs 0 and 1, respectively, while the "gate machinery" included the rest of the system, see Oxaloacetate generated by the joint activity of the two input enzymes was converted to citrate with the help of the third enzyme, citrate synthase. This reaction fostered generation of the species capable of dissolving the alginate microspheres and releasing a drug-mimicking dye. It is worth mentioning that the byproduct of the third biocatalytic reaction, CoASH, was analyzed through its reaction with DTNB, Scheme 1. Since CoASH was produced in the 1:1 stoichiometry to citrate, the concentration of citrate was determined on the basis of production of CoASH in the presence of different combinations of the enzyme-input signals, Scheme 1, inset. Application of the 1,1 input combination corresponding to the liver injury resulted in 1 mM citrate after 60 min reaction, while the highest citrate concentration corresponding to the conditions different from liver injury was ca. 3-fold lower (0.34 mM) and it was achieved at the 1,0 input combination. After 1 h the activity of enzymes comes to saturation, so after that time increase in citrate concentration was not observed. Aiming at the drug-mimicking release -10 -triggered specifically by the 1,1 input combination corresponding to the liver injury, the kinetics of dissolution of the alginate microspheres should be significantly different in the presence of 0. 34 Additional information on the properties of the APA microspheres, specifically, the process of release of the dye from the microspheres, can be obtained in experiments -12 -whereby the dye diffuses without any initial mixing, upwards along the cuvette from its bottom where a single microsphere is located. Figure 5 shows the data sets taken for various concentrations of citrate. A standard diffusion theory was used for the timedependence of the cross-section-averaged concentration at height, x, upwards along the cuvette, similarly to the method used in the previous work. 92 The concentration, c(x,t) , averaged over the cuvette cross-section, was measured by fluorescent spectroscopy at x = 6 mm, as described in the experimental section. The diffusion equation assuming that the microsphere size is small as compared to other dimensions, was taken as ,
for 0 ∞, with the reflecting boundary condition at x = 0, and with the source term, , is known. 93 We assume that the time scale of dissolution of the shell is t 0 , after which the core of radius R 0 remains, containing N molecules of dye. As this core is decomposed, or the dye is leached out from it, the radius of the remaining dye-containing spherical volume, R(t), will decrease to zero. This process involves another time scale, t c . The quality of the available data only allows extraction of information on these two parameters, and therefore a relatively simple model of the dye etching should be used. For the present system, the concentration of the dye in the solution is too low, and its transport away from the dissolving core too fast to affect the rate of dye release. Basically, this corresponds to the assumption that in the Noyes-Whitney law, 94 the concentration gradient in the near-surface diffusion-controlled layer is not significantly time-or coresize dependent, and that the external (to that layer) concentration is small as compared to the internal one (at the dissolving core surface). Then the dye is released at a constant rate per unit area of the core of radius R(t), and therefore the volume, 4 /3, of the -13 -dye-containing core shrinks according to ∝ 4 . One can then easily show that this approach leads to a linear decrease 1 . Thus, the core radius decreases from R 0 at t 0 to zero at time t 0 + t c . The amount of dye released can then be calculated, and the source term in the diffusion equation turns out to be given by for times t 0 < t < t 0 + t c , and S(t) = 0 otherwise, where A is the cross-section area of the cuvette.
The diffusion equation can now be solved analytically for 0 ∞, where no upper limit is assumed because it can be estimated that the height of the column of solution in the cuvette, 12 mm, will affect the concentration only after times of approximately 700 min, safely outside our measurement range (we also tested the latter assumption by numerical solutions with the reflecting boundary condition at the top of the liquid column). For t 0 ≤ t ≤ t 0 + t c , we get
with the upper limit of integration replaced by t 0 + t c for t > t 0 + t c , and obviously c(x,t) = 0 for t < t 0 . Least-squares data-fitting results, using the standard approaches (including error estimates), 95 are presented in Table 1 (see page 24 ). The sums of the times, t 0 + t c , are generally consistent with the earlier estimates for the overall time of the dye concentration buildup measured by the microsphere dissolution in the system with mixing.
The diffusion-theory study clearly confirms that two separate time scales are involved in the process. This is illustrated in Figure 6 , in which we used experimental parameters for all the quantities but the time scales. We note that the time scale t 0 simply represents the offset in the concentration buildup to positive times, due to the need to first dissolve the shell. A single additional time scale for the dye-containing core decomposition, here illustrated by varying t c values, cannot modify this offset. Rather, -14 -increasing it leads to slower concentration buildup at the distance x from the cuvette bottom. Note that for larger times than those of our experiment, the concentration at x will actually decrease, to zero if there is no reflecting liquid-column top -as assumed for Equation (2) . Our time-dependence form for the remaining dye-containing core radius is sketched in the inset in Figure 6 . In reality, the effective radius R eff defined, for instance, via R eff (t)/R 0 = (n(t)/N) 3 , were n(t) is the remaining undissolved dye at time t, with n(0) = N, is likely a smooth function of time, but requiring two time scales for describing its time dependence: one for the shall and the other for the dye-containing core.
CONCLUSIONS
The present study has demonstrated that the drug-mimicking release process can be Despite the fact that the studied system aims only at the demonstration of the concept, practical applications are feasible. However, after the successful implementation of the AND logic operation to the drug-mimicking release process still there are unsolved problems which require additional work. The present study was performed using solutions artificially spiked with the biomarker-inputs mimicking normal physiological and pathophysiological conditions (defined as logic 0 and 1 inputs, respectively). In the continued study the inputs should be natural biologically produced materials obtained from animal or human biomedical samples, similarly to our recent study where porcine samples were applied for the logic analysis of liver injury biomarkers. 99 It has been already shown that similar binary logic systems processing injury biomarkers can operate in human serum solutions. 80, 96 Preliminary experiments also demonstrated that Fe -crosslinked alginate thin-films can be applied for encapsulation and triggered release of lysozyme, which is a real antimicrobial drug. 100 In the next step of the project, which is underway, real drug compensating liver injury problems will be used instead of a drug-mimicking dye. This approach will also be -16 -extended to other biomarkers signaling different kinds of pathophysiological problems, and the alginate microspheres will be loaded with the corresponding drugs.
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This work was supported by the NSF (Award # CBET-1066531). The kinetic was derived from the fluorescence images similar to those shown in Figure 2 and it was measured as the pixel brightness in a square marked in image (C) and in other similar images, Figure 2 . The same image area was analyzed for brightness in all images recorded over the reaction time.
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